PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release

References

• Li Z, Guan J. Thermosensitive hydrogels for drug delivery. Expert Opin. Drug Delivery. 2011;8:991–1007.
   PubMed Web of Science ®Google Scholar
• Wei L, Cai CH, Lin JP, Chen T. Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials. 2009;30:2606–2613.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Gunn J, Zhang MQ. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Delivery Rev. 2010;62:83–99.
   PubMed Web of Science ®Google Scholar
• Jin R, Teixeira LSM, Dijkstra PJ, Karperien M, van Blitterswijk CA, Zhong ZY, Feijen J. Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials. 2009;30:2544–2551.
   PubMed Web of Science ®Google Scholar
• Azab AK, Orkin B, Doviner V, Nissan A, Klein M, Srebnik M, Rubinstein A. Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis. J. Controlled Release. 2006;111:281–289.
   Google Scholar
• Wang Y, Chen M, Li X, Huang Y, Liang W. A hybrid thermo-sensitive chitosan gel for sustained release of Meloxicam. J. Biomater. Sci., Polym. Ed. 2008;19:1239–1247.
   PubMed Web of Science ®Google Scholar
• Zan J, Chen HH, Jiang GQ, Lin Y, Ding FX. Preparation and properties of crosslinked chitosan thermosensitive hydrogel for injectable drug delivery systems. J. Appl. Polym. Sci. 2006;101:1892–1898.
   Web of Science ®Google Scholar
• Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, Leroux JC. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm. Biopharm. 2004;57:53–63.
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 2002;233:217–225.
   PubMed Web of Science ®Google Scholar
• Tosatti S, De Paul SM, Askendal A, Vande Vondele S, Hubbell JA, Tengvall P, Textor M. Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials. 2003;24:4949–4958.
   PubMed Web of Science ®Google Scholar
• Hoemann CD, Sun J, Legare A, McKee MD, Buschmann MD. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr. Cartilage. 2005;13:318–329.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Ramay HR, Gunn J, Matsen FA, Zhang MQ. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Controlled Release. 2005;103:609–624.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Matsen FA, Zhang M. PEG-grafted chitosan as an injectable thermoreversible hydrogel. Macromol. Biosci. 2005;5:107–111.
   PubMed Web of Science ®Google Scholar
• Liang Y, Deng L, Chen C, Zhang J, Zhou R, Li X, Hu R, Dong A. Preparation and properties of thermoreversible hydrogels based on methoxy poly(ethylene glycol)-grafted chitosan nanoparticles for drug delivery systems. Carbohydr. Polym. 2011;83:1828–1833.
   Web of Science ®Google Scholar
• Molinaro G, Leroux JC, Damas J, Adam A. Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials. 2002;23:2717–2722.
   PubMed Web of Science ®Google Scholar
• Sun JL, Jiang GQ, Qiu TT, Wang YJ, Zhang K, Ding FX. Injectable chitosan-based hydrogel for implantable drug delivery: body response and induced variations of structure and composition. J. Biomed. Mater. Res., Part A. 2010;95A:1019–1027.
   Google Scholar
• Sun J, Jiang G, Wang Y, Ding F. Thermosensitive chitosan hydrogel for implantable drug delivery: blending PVA to mitigate body response and promote bioavailability. J. Appl. Polym. Sci. 2012;125:2092–2101.
   Web of Science ®Google Scholar
• Harris JM, Struck EC, Case MG, Paley MS, Vanalstine JM, Brooks DE. Synthesis and characterization of Poly(Ethylene Glycol) derivatives. J. Polym. Sci., Part A: Polym. Chem. 1984;22:341–352.
   Web of Science ®Google Scholar
• Inukai Y, Chinen T, Matsuda T, Kaida Y, Yasuda SJ. Selective separation of germanium(IV) by 2,3-dihydroxypropyl chitosan resin. Anal. Chim. Acta. 1998;371:187–193.
   Web of Science ®Google Scholar
• Stammen JA, Williams S, Ku DN, Guldberg RE. Mechanical properties of a novel PVA hydrogel in shear and unconfined compression. Biomaterials. 2001;22:799–806.
   PubMed Web of Science ®Google Scholar
• Ren DW, Yi HF, Wang W, Ma XJ. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydr. Res. 2005;340:2403–2410.
   PubMed Web of Science ®Google Scholar
• Dai JD, Nagai T, Wang XQ, Zhang T, Meng M, Zhang Q. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int. J. Pharm. 2004;280:229–240.
   PubMed Web of Science ®Google Scholar
• Chimalakonda AP, Shah RB, Mehvar R. High-performance liquid chromatographic analysis of cyclosporin A in rat blood and liver using a commercially available internal standard. J. Chromatogr. B-Anal. Technol. Biomed. Life Sci. 2002;772:107–114.
   PubMed Web of Science ®Google Scholar
• Philippova OE, Volkov EV, Sitnikova NL, Khokhlov AR, Desbrieres J, Rinaudo M. Two types of hydrophobic aggregates in aqueous solutions of chitosan and its hydrophobic derivative. Biomacromolecules. 2001;2:483–490.
   PubMed Web of Science ®Google Scholar
• Ruiz-Caro R, Veiga MD, Di Meo C, Cencetti C, Coviello T, Matricardi P, Alhaique F. Mechanical and drug delivery properties of a chitosan-tartaric acid hydrogel suitable for biomedical applications. J. Appl. Polym. Sci. 2012;123:842–849.
   Web of Science ®Google Scholar
• Mehrotra S, Lynam D, Liu C, Shahriari D, Lee I, Tuszynski M, Sakamoto J, Chan C. Time controlled release of arabinofuranosylcytosine (Ara-C) from agarose hydrogels using layer-by-layer assembly: an in vitro study. J. Biomater. Sci., Polym. Ed. 2012;23:439–463.
   PubMed Web of Science ®Google Scholar
• Goreish HH, Lewis AL, Rose S, Lloyd AW. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: In vitro and in vivo observations. J. Biomed. Mater. Res., Part A. 2004;68A:1–9.
   Google Scholar
• Su J, Hu B-H, Lowe WL, Jr., Kaufman DB, Messersmith PB. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials. 2010;31:308–314.
   PubMed Web of Science ®Google Scholar
• He W, McConnell GC, Schneider TM, Bellamkonda RV. A novel anti-inflammatory surface for neural electrodes. Adv. Mater. 2007;19:3529–3533.
   Web of Science ®Google Scholar
• Kang GD, Cheon SH, Khang G, Song SC. Thermosensitive poly(organophosphazene) hydrogels for a controlled drug delivery. Eur. J. Pharm. Biopharm. 2006;63:340–346.
   PubMed Web of Science ®Google Scholar
• Cabrera MI, Grau RJA. A generalized integral method for solving the design equations of dissolution/diffusion-controlled drug release from planar, cylindrical and spherical matrix devices. J. Membr. Sci. 2007;293:1–14.
   Google Scholar
• Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporine. Clin. Pharmacokinet. 1986;11:107–132.
   PubMed Web of Science ®Google Scholar
• Kahan BD. Drug therapy -cyclosporine New England. J. Med. 1989;321:1725–1738.
   Google Scholar
• Woo JS, Piao MG, Li DX, Ryu D-S, Choi JY, Kim J-A, Kim JH, Jin SG, Kim D-D, Lyoo WS, Yong CS, Choi H-G. Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability. Int. J. Pharm. 2007;345:134–141.
   PubMed Web of Science ®Google Scholar
• Malaekeh-Nikouei B, Tabassi SAS, Jaafari MR. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A. Drug Dev. Ind. Pharm. 2008;34:492–498.
   PubMed Web of Science ®Google Scholar
• Hirunpanich V, Sato H. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient. Eur. J. Pharm. Biopharm. 2009;73:247–252.
   PubMed Web of Science ®Google Scholar
• Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S. In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. J. Controlled Release. 2009;138:16–23.
   PubMed Web of Science ®Google Scholar
• Lee SS, Kim H, Wang NS, Bungay PM, Gilger BC, Yuan P, Kim J, Csaky KG, Robinson MR. A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection. Invest. Ophthalmol. Visual Sci. 2007;48:2023–2029.
   Google Scholar